We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

By HospiMedica International staff writers
Posted on 04 Feb 2026

Immunotherapy has transformed cancer care, but many patients either fail to respond or develop severe side effects that force treatment to stop early. More...

In kidney cancer, lung cancer, and melanoma, immune-related complications such as colitis and diarrhea can significantly reduce quality of life and limit survival benefits. At the same time, response rates to immunotherapy remain inconsistent across cancer types. New clinical studies now show that modifying the gut microbiome can both reduce treatment toxicity and substantially improve patient response to immunotherapy.

In research led by Lawson Research Institute (Ontario, Canada), in collaboration with London Health Sciences Centre Research Institute (LHSCRI, Ontario, Canada) and clinical partners, scientists have developed advanced oral fecal microbiota transplant capsules, known as LND101, created from healthy donor stool and designed to restore a balanced gut microbiome safely. The capsules are standardized, scalable, and easy to administer, making them suitable for use alongside cancer immunotherapy in clinical settings.

In a Phase I clinical trial, researchers evaluated whether FMT could be safely combined with immunotherapy in patients with advanced kidney cancer. The study involved 20 patients treated at a specialized cancer center and focused on reducing immune-related side effects that often limit therapy. The findings, published in Nature Medicine, showed that customized FMT could significantly reduce gastrointestinal toxicity without compromising cancer treatment.

Separate Phase II trials examined the effect of FMT on immunotherapy response in lung cancer and melanoma. In lung cancer patients, 80 percent responded to immunotherapy after receiving FMT, compared with the typical 39–45 percent response rate seen with immunotherapy alone. In melanoma, 75 percent of patients responded following FMT, compared with about 50–58 percent in standard treatment, demonstrating a marked improvement across both cancer types.

Together, the studies suggest that fecal microbiota transplantation can both enhance immunotherapy effectiveness and reduce harmful side effects, addressing two major limitations of current cancer treatments. By reshaping the gut microbiome, FMT appears to remove harmful bacteria and promote immune responses that better target tumors. Researchers are now expanding this approach through larger randomized trials, including pan-Canadian studies, and exploring its potential in other cancers such as pancreatic and triple-negative breast cancer.

“Our clinical trials show that fecal microbiota transplantation can both reduce immunotherapy toxicity and significantly improve treatment response,” said Dr. Arielle Elkrief, Physician Scientist and Co-Principal Investigator, who was involved in the lung cancer and melanoma studies. “These results open a new path toward personalized microbiome-based therapies in oncology.”

Related Links:
Lawson Research Institute
LHSCRI


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hybrid Arch Device
Neo EDE
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
From left: Mr Ng Tian Chong, Chief Executive Officer, Singtel Singapore; Professor Yeoh Khay Guan, Chief Executive, NUHS; and Mr Daniel Ode, Head of Ericsson Singapore, Brunei and Philippines and Global Customer Unit Singtel, signed a Memorandum of Understanding to advance connected healthcare, 5G-Advanced and 6G technology, as well as connected intelligence. (Photo courtesy of National University Health System)

Healthcare Partnership Creates Testbed for Advanced Connectivity and AI Applications

Hospitals face growing care complexity, aging populations, and pressure to extend monitoring beyond traditional inpatient settings. Meeting these demands requires more responsive clinical workflows and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.